Nutr Res Pract.  2022 Dec;16(6):700-715. 10.4162/nrp.2022.16.6.700.

Differential effects of various dietary proteins on dextran sulfate sodiuminduced colitis in mice

Affiliations
  • 1Department of Food Science and Nutrition, Daegu Catholic University, Gyeongsan 38430, Korea
  • 2Gyeongsangbuk-do Institute of Health & Environment, Yeongcheon 38874, Korea

Abstract

BACKGROUND/OBJECTIVES
Chronic colitis is a risk factor for colorectal cancer (CRC) development in both animals and humans. Previously, we reported that a diet rich in protein (with casein as the protein source) significantly increased the risk of mouse CRC development in a dose-dependent manner. In this study, we investigated the effects of different protein sources on the risk of colitis development.
MATERIALS/METHODS
Balb/c mice were divided into 7 experimental groups: 20% casein (20C), 20C-dextran sulfate sodium (DSS), 40% casein-DSS (40CD), 40% whey protein-DSS (40WD), 40% soy protein-DSS (40SD), 40% white meat-DSS (40WMD), and 40% red meatDSS (40RMD). Mice were fed an experimental diet for 4 wk and received 3% DSS in their drinking water for 6 days during the 4th wk of the experimental period.
RESULTS
Compared to other groups, the 40CD group showed the most aggravated colitis with increased disease activity and inflammatory markers. In the 40RMD group, interleukin (IL)-6 levels were the highest among all the groups. The 40SD group showed conflicting effects, for example, elevated mortality and disease activity but decreased nitric oxide (NO) levels. The 40WD group showed attenuated colitis with increased IL-10 levels and decreased NO levels. The 40WMD group showed conflicting effects, including decreased NO levels and elevated fecal lipocalin-2 and IL-6 levels.
CONCLUSIONS
These results suggest that, at levels of 40% in the diet, casein and red meat exacerbate colitis, whereas whey protein mitigates it the most effectively.

Keyword

High protein diet; colitis; mouse; inflammation; dextran sulfate sodium

Figure

  • Fig. 1 Schematic representation of experimental design. Female Balb/c mice were divided into 7 diet groups: 20C (control), 20CD, 40CD, 40WD, 40SD, 40WMD, 40RMD. Animals were fed experimental diet for total 4 wk and were received 3% DSS in their drinking water for 6 days on the 3rd wk of the experiment.DSS, dextran sulfate sodium; 20C, 20% casein; 20CD, 20% casein-DSS; 40CD, 40% casein-DSS; 40WD, 40% whey protein-DSS; 40SD, 40% soy protein-DSS; 40WMD, 40% white meat-DSS; 40RMD, 40% red meat-DSS.

  • Fig. 2 Effect of various protein sources on the colitis activity. Female Balb/c mice in 20CD, 40CD, 40WD, 40SD, 40WMD, 40RMD group were administered 3% DSS in drinking water for 6 days. Control group received tap water. (A) Disease activity index of mice was monitored during DSS treatment. (B) The survival rate of mice was monitored during and after 2 days of the DSS treatment. (C) The weight and length of entire large intestine was measured and the weight/length ratio was calculated. (D) MPO activities were assayed in colorectal tissue. (E) Colorectal tissue sections were stained with hematoxylin and eosin. Representative histological pictures of mice are shown at 40× magnification. Means with different letters are significantly different at P < 0.05 by Duncan’s multiple range test.20C, 20% casein; 20CD, 20% casein-DSS; 40CD, 40% casein-DSS; 40WD, 40% whey protein-DSS; 40SD, 40% soy protein-DSS; 40WMD, 40% white meat-DSS; 40RMD, 40% red meat-DSS; DSS, dextran sulfate sodium; MPO, myeloperoxidase.

  • Fig. 3 The changes of inflammatory markers and tight junction protein on various sources of high protein diet fed DSS-induced colitis mice. Acute distal colitis was induced by DSS in drinking water. (A) The mRNA levels of ZO-1 and occludin which function tight junction were measured using RT-PCR. (B) The mRNA levels of TNF-α, IL-6, and IL-10 were measured using RT-PCR. (C) The inflammatory markers were determined by western blot with the appropriate antibodies. Data are presented as representative blots. The protein level of COX-2 was presented. The GAPDH level was used as a control. (D) The level of plasma NO was collected and examined as described in the Materials and Methods. Means with different letters are significantly different at P < 0.05% by Duncan’s multiple range test.mRNA, messenger RNA; ZO-1, zonula occludens-1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; 20C, 20% casein; 20CD, 20% casein-DSS; 40CD, 40% casein-DSS; 40WD, 40% whey protein-DSS; 40SD, 40% soy-DSS; 40WMD, 40% white meat-DSS; 40RMD, 40% red meat-DSS; TNF-α, tumor necrosis factor alpha; IL, interleukin; COX-2, cyclooxygenase; DSS, dextran sulfate sodium; RT-PCR, reverse transcription polymerase chain reaction.

  • Fig. 4 Changes in Lcn-2 and ammonia levels in the feces of DSS-induced colitis mice fed high protein diet of various sources. Mouse feces for each experimental group were collected during the last 3 days of the colitis experiment. (A) The amount of Lcn-2 was measured in the feces of the mouse. (B) The level of ammonia on fecal samples was analyzed as described in the Methods and materials. Means with different letters are significantly different at P < 0.05% by Duncan’s multiple range test.Lcn-2, lipocalin-2; 20C, 20% casein; 20CD, 20% casein-DSS; 40CD, 40% casein-DSS; 40WD, 40% whey protein-DSS; 40SD, 40% soy-DSS; 40WMD, 40% white meat-DSS; 40RMD, 40% red meat-DSS; DSS, dextran sulfate sodium.

  • Fig. 5 The levels of fecal short-chain fatty acids in DSS-induced colitis mouse fed various sources of high protein diet. (A) The content of fecal short-chain fatty acids which include acetate, propionate, and butyrate, were measured. (B) The mRNA levels of (MCT1 and SMCT1 on colorectal tissue were measured using reverse transcription polymerase chain reaction. The GAPDH level was used as a control. Means with different letters are significantly different at P < 0.05% by Duncan’s multiple range test.20C, 20% casein; 20CD, 20% casein-DSS; 40CD, 40% casein-DSS; 40WD, 40% whey protein-DSS; 40SD, 40% soy-DSS; 40WMD, 40% white meat-DSS; 40RMD, 40% red meat-DSS; mRNA, messenger RNA; MCT1, monocarboxylate transporter 1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; SMCT1, sodium-coupled monocarboxylate transporter 1; DSS, dextran sulfate sodium.


Reference

1. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010; 6:339–346. PMID: 20567592.
2. Keshteli AH, Madsen KL, Dieleman LA. Diet in the pathogenesis and management of ulcerative colitis; a review of randomized controlled dietary interventions. Nutrients. 2019; 11:1498. PMID: 31262022.
Article
3. Benchimol EI, Mack DR, Guttmann A, Nguyen GC, To T, Mojaverian N, Quach P, Manuel DG. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol. 2015; 110:553–563. PMID: 25756238.
Article
4. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454:436–444. PMID: 18650914.
Article
5. Kim YH, Kwon HS, Kim DH, Cho HJ, Lee HS, Jun JG, Park JHY, Kim JK. Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis. Int Immunopharmacol. 2008; 8:1695–1702. PMID: 18773974.
Article
6. Byun SY, Kim DB, Kim E. Curcumin ameliorates the tumor-enhancing effects of a high-protein diet in an azoxymethane-induced mouse model of colon carcinogenesis. Nutr Res. 2015; 35:726–735. PMID: 26094212.
Article
7. Lan A, Blais A, Coelho D, Capron J, Maarouf M, Benamouzig R, Lancha AH Jr, Walker F, Tomé D, Blachier F. Dual effects of a high-protein diet on DSS-treated mice during colitis resolution phase. Am J Physiol Gastrointest Liver Physiol. 2016; 311:G624–G633. PMID: 27562061.
Article
8. Tak KH, Ahn E, Kim E. Increase in dietary protein content exacerbates colonic inflammation and tumorigenesis in azoxymethane-induced mouse colon carcinogenesis. Nutr Res Pract. 2017; 11:281–289. PMID: 28765774.
Article
9. Vidal-Lletjós S, Beaumont M, Tomé D, Benamouzig R, Blachier F, Lan A. Dietary protein and amino acid supplementation in inflammatory bowel disease course: what impact on the colonic mucosa? Nutrients. 2017; 9:310. PMID: 28335546.
Article
10. van Nuenen MH, Venema K, van der Woude JC, Kuipers EJ. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci. 2004; 49:485–491. PMID: 15139503.
Article
11. Jiang H, Przybyszewski J, Mitra D, Becker C, Brehm-Stecher B, Tentinger A, MacDonald RS. Soy protein diet, but not Lactobacillus rhamnosus GG, decreases mucin-1, trefoil factor-3, and tumor necrosis factor-α in colon of dextran sodium sulfate-treated C57BL/6 mice. J Nutr. 2011; 141:1239–1246. PMID: 21593350.
Article
12. McIntosh GH, Regester GO, Le Leu RK, Royle PJ, Smithers GW. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr. 1995; 125:809–816. PMID: 7722681.
13. Belobrajdic DP, McIntosh GH, Owens JA. Whey proteins protect more than red meat against azoxymethane induced ACF in Wistar rats. Cancer Lett. 2003; 198:43–51. PMID: 12893429.
Article
14. Pandurangan AK, Mohebali N, Norhaizan ME, Looi CY. Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug Des Devel Ther. 2015; 9:3923–3934.
Article
15. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29:e45. PMID: 11328886.
Article
16. Han X, Guo J, You Y, Yin M, Ren C, Zhan J, Huang W. A fast and accurate way to determine short chain fatty acids in mouse feces based on GC-MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1099:73–82.
Article
17. Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012; 7:e44328. PMID: 22957064.
Article
18. Mouillé B, Robert V, Blachier F. Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion. Am J Physiol Gastrointest Liver Physiol. 2004; 287:G344–G351. PMID: 15064231.
Article
19. Topping DC, Visek WJ. Synthesis of macromolecules by intestinal cells incubated with ammonia. Am J Physiol. 1977; 233:E341–E347. PMID: 910948.
Article
20. Ichikawa H, Sakata T. Stimulation of epithelial cell proliferation of isolated distal colon of rats by continuous colonic infusion of ammonia or short-chain fatty acids is nonadditive. J Nutr. 1998; 128:843–847. PMID: 9566991.
Article
21. Cremin JD Jr, Fitch MD, Fleming SE. Glucose alleviates ammonia-induced inhibition of short-chain fatty acid metabolism in rat colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2003; 285:G105–G114. PMID: 12637251.
Article
22. Le Leu RK, Young GP, Hu Y, Winter J, Conlon MA. Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci. 2013; 58:3475–3482. PMID: 23990000.
Article
23. McIntosh GH, Le Leu RK. The influence of dietary proteins on colon cancer risk. Nutr Res. 2001; 21:1053–1066. PMID: 11446989.
Article
24. Shi J, Zhao D, Song S, Zhang M, Zamaratskaia G, Xu X, Zhou G, Li C. High-meat-protein high-fat diet induced dysbiosis of gut microbiota and tryptophan metabolism in Wistar rats. J Agric Food Chem. 2020; 68:6333–6346. PMID: 32432868.
Article
25. Ronis MJ, Hakkak R, Korourian S, Badger TM. Whey protein hydrolysate but not whole whey protein protects against 7, 12-dimethylbenz (a) anthracene-induced mammary tumors in rats. Nutr Cancer. 2015; 67:949–953. PMID: 26168336.
Article
26. Yu Y, Jing X, Li H, Zhao X, Wang D. Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis. Sci Rep. 2016; 6:25939. PMID: 27170217.
Article
27. Guo YW, Chen YH, Chiu WC, Liao H, Lin SH. Soy saponins meditate the progression of colon cancer in rats by inhibiting the activity of β-glucuronidase and the number of aberrant crypt foci but not cyclooxygenase-2 activity. ISRN Oncol. 2013; 2013:645817. PMID: 24224098.
28. Govers MJ, Lapré JA, De Vries HT, Van der Meer R. Dietary soybean protein compared with casein damages colonic epithelium and stimulates colonic epithelial proliferation in rats. J Nutr. 1993; 123:1709–1713. PMID: 8410362.
Article
29. Pan L, Farouk MH, Qin G, Zhao Y, Bao N. The influences of soybean agglutinin and functional oligosaccharides on the intestinal tract of monogastric animals. Int J Mol Sci. 2018; 19:554. PMID: 29439523.
Article
30. Badger TM, Ronis MJ, Hakkak R. Developmental effects and health aspects of soy protein isolate, casein, and whey in male and female rats. Int J Toxicol. 2001; 20:165–174. PMID: 11488559.
Article
31. Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R. Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila). 2011; 4:1903–1911. PMID: 21803982.
Article
32. Ollberding NJ, Wilkens LR, Henderson BE, Kolonel LN, Le Marchand L. Meat consumption, heterocyclic amines and colorectal cancer risk: the Multiethnic Cohort Study. Int J Cancer. 2012; 131:E1125–E1133. PMID: 22438055.
Article
33. Samraj AN, Pearce OM, Läubli H, Crittenden AN, Bergfeld AK, Banda K, Gregg CJ, Bingman AE, Secrest P, Diaz SL, et al. A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci U S A. 2015; 112:542–547. PMID: 25548184.
Article
34. Zhu Y, Lin X, Zhao F, Shi X, Li H, Li Y, Zhu W, Xu X, Li C, Zhou G. Meat, dairy and plant proteins alter bacterial composition of rat gut bacteria. Sci Rep. 2015; 5:15220. PMID: 26463271.
Article
35. Thibault R, De Coppet P, Daly K, Bourreille A, Cuff M, Bonnet C, Mosnier JF, Galmiche JP, Shirazi-Beechey S, Segain JP. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology. 2007; 133:1916–1927. PMID: 18054563.
Article
36. Kostovcikova K, Coufal S, Galanova N, Fajstova A, Hudcovic T, Kostovcik M, Prochazkova P, Jiraskova Zakostelska Z, Cermakova M, Sediva B, et al. Diet rich in animal protein promotes pro-inflammatory macrophage response and exacerbates colitis in mice. Front Immunol. 2019; 10:919. PMID: 31105710.
Article
37. Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain JP. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis. 2010; 16:684–695. PMID: 19774643.
Article
Full Text Links
  • NRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr